Mode
Text Size
Log in / Sign up
N/A N=78 Randomized Single-blind Supportive Care

Nursing Interventions Based on Protection Motivation Theory in Hypertensive Patients

Hypertension, Public Health; Nursing Staff

Enrolled (actual)
78
Serious AEs
0.0%
Results posted
Jun 2025
Primary outcome: Primary: Scale of Adherence to Antihypertensive Drug Treatment — 9.31; 9.51; 7.86; 9.23 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Nursing interventions based on protection motivation theory in patients with hypertension (Behavioral)
Age
Adult · 40+ yrs
Sex
All
Sponsor
Necmettin Erbakan University
Primary completion
Mar 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Scale of Adherence to Antihypertensive Drug Treatment
9.31; 9.51; 7.86; 9.23; 8.14; 9.23
PRIMARY
Healthy Lifestyle Behaviors Scale
119.90; 119.05; 132.11; 122.23; 131.53; 121.97
SECONDARY
Systolic Blood Pressure
148.46; 147.82; 140.56; 148.14; 136.81; 148.86
SECONDARY
Diastolic Blood Pressure
93.08; 92.05; 87.78; 90.57; 87.78; 90.43

Summary

Hypertension is a major global public health problem. In order to be successful in hypertension management, patients should receive timely and accurate diagnosis, acquire healthy lifestyle habits, start antihypertensive drug treatment on time, and ensure compliance with treatment. The study was conducted in a pre-test-post-test parallel group randomized controlled design in order to determine the effects of nursing interventions consisting of Rogers' Protection Motivation Terosine-based hypertension education and sending short messages to hypertensive individuals on medication compliance and healthy lifestyle behaviors. The study was conducted in Karaman Province, Family Health Center No. 7 between November 2023 and May 2024. The study group consisted of individuals aged between 40-59 years, with low compliance to treatment, no communication problems in terms of hearing, vision and understanding, using mobile phones, and diagnosed with primary hypertension. The study was conducted with a total of 78 participants, 39 in the intervention group and 39 in the control group, calculated with 95% power. Before starting the study, ethics committee, institution, scale usage permission and written consent were obtained from the participants. Data were collected using Personal Information Form, Antihypertensive Drug Treatment Adherence Scale, Healthy Lifestyle Behaviors Scale, Blood Pressure Monitoring Form at the beginning (T₀), end of the third month (T₁) and end of the sixth month (T₂). Multiple nursing interventions consisting of hypertension education, brochure and 14-week short messages were applied to the intervention group. No intervention was applied to the control group. Measurements were collected by face-to-face interview method. Blinding was applied in terms of statistics expert and reporting. Data analyses in this study were performed using IBM SPSS Statistics Standard Concurrent User V 26 (IBM Corp., Armonk, New York, USA) program. After the applied nursing interventions, a significant difference was found between the total mean score of the Antihypertensive Drug Treatment Adherence Scale, the mean score of the Healthy Lifestyle Behaviors Scale, and systolic blood pressure and diastolic blood pressure values of the intervention and control groups (p<0.05). As a result, applicable, economical interventions combining health education and technology can be recommended as an important tool in health services to reduce the burden of hypertension in society.

Eligibility Criteria

Inclusion Criteria

  • Participants who have been diagnosed with primary hypertension (at least one year)
  • Those between the ages of 40 and 59
  • Those who use a mobile phone to receive SMS messages sent by the researcher
  • Those who are at least literate and can speak Turkish
  • Those who have no communication problems in terms of hearing, seeing and understanding
  • Those who use antihypertensive medication and who score "8 and above" on the compliance scale and are defined as non-compliant with treatment were decided to be included in the study.

Exclusion Criteria

  • Having a second chronic disease
  • Those with mental or communication problems
  • Those with secondary hypertension (Addison's disease, Renal artery stenosis, Hypo/hyperthyroidism, Parenchymal kidney disease, Cushing's Disease)
  • Pregnant or lactating,
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05995977). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search